-The Times of India MUMBAI: Turf war between Big pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. Triggering a full-blown patent fight with US-based Merck, domestic generic company Glenmark has launched a more affordable version of the multinational's blockbuster...

-First Post While the average Human Development Index (HDI) for the region is 0.558, below the world average of 0.693, South Asia saw the highest growth in the index between 2000 and 2012, according to the United Nations Human Development Report 2013. The region registered an annual growth of 1.43 percent in HDI, the highest compared to other regions. It also said that the developing countries as a whole are driving the...

-Outlook This could be the UPA’s worst cut to its beloved aam admi. Healthcare has virtually been handed over to privateers. Not For Those Who Need It Most Govt seems to have abandoned healthcare to the private sector Diagnosing An Ailing Republic     70 per cent of India still lives in the villages, where only two per cent of qualified allopathic doctors are available     Due to lack of access to medical care, rural India...

-PTI Washington: Early breast cancer diagnosis and survival rates are very low among women living in rural India compared to those in developed nations, a new study has claimed. Researchers said women in developed countries survive roughly 10 years longer after a breast cancer diagnosis compared to women in poor-to-middle-income countries. The study by University of Michigan demonstrates the lack of access to good health care faced by women in poor countries, said...

-Frontine Walmart’s disclosure that it spent huge amounts of money on lobbying in India and the allegation that it entered the retail sector through indirect means highlight the power of global capital in dictating the country’s policies. The world’s largest multi-brand retailer Walmart’s disclosure to the United States Senate that it had spent $25 million (Rs.135 crore) since 2008 on its various lobbying activities, which include enhancing access to the Indian...